Skip to main content
BioMed Research International logoLink to BioMed Research International
. 2017 Jul 18;2017:5782619. doi: 10.1155/2017/5782619

Corrigendum to “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma”

Ling-Gang Cheng 1, Wen He 1, Hong-Xia Zhang 1,*, Qian Song 1, Bin Ning 1, Hui-Zhan Li 1, Yan He 1, Song Lin 2
PMCID: PMC5541787  PMID: 28808660

In the article titled “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma” [1], there were errors in the Materials and Methods and Results sections, as mentioned in a Letter to the Editor by Mahalangikar et al. [2], which should be corrected as follows.

In Section  2.7.3 (Expression of VEGF), “41% to 75% was (+)” should be corrected to “41% to 75% was (+ +).”

The age ranges were incorrectly reported in Section  3.1 (The Basic Condition of the Patients) as “20 to 69 years with a mean age of 47.9 ± 11.4” and should be corrected to “18 to 69 years with a mean age of 45 ± 12.8 years.”

References

  • 1.Cheng L.-G., He W., Zhang H.-X., et al. Intraoperative contrast enhanced ultrasound evaluates the grade of glioma. BioMed Research International. 2016;2016:9. doi: 10.1155/2016/2643862.2643862 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mahalangikar R., Sinha S., Sharma R. Comment on ‘intraoperative contrast enhanced ultrasound evaluates the grade of glioma’. BioMed Research International. 2017;2017:2. doi: 10.1155/2017/3570895.3570895 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES